BEGIN:VCALENDAR
PRODID:-//AT Content Types//AT Event//EN
VERSION:1.0
BEGIN:VEVENT
DTSTART:20130220T190000Z
DTEND:20130220T200000Z
DCREATED:20130218T184938Z
UID:ATEvent-cb9ded9e7f9c44e8b79fed495bf95642
SEQUENCE:0
LAST-MODIFIED:20130218T184956Z
SUMMARY:Metabolomics in exploratory toxicology\: Consequences of treatment with the candidate chemopreventive agent pentamethylchromanol (PMCol)
DESCRIPTION:Jonathan McDunn\, PhD.\,  Associate Director\, Diagnostics
  Research and Development at Metabolomic Inc. and Adjunct Associate Pr
 ofessor of Biomedical Engineering\, UNC-Chapel Hill
LOCATION:G-605 Koury
PRIORITY:3
TRANSP:0
END:VEVENT
END:VCALENDAR